Výsledky vyhledávání

Platinum-based chemotherapy (chemo) with CS1001, an anti-PD-L1 antibody, for first-line advanced non-small cell lung cancer (NSCLC): Preliminary results from phase Ib cohorts of CS1001-101 study

Autor: Lin Shen, Yi-Long Wu, Quanli Gao, Teddy Xia, Qingyuan Zhang, Zhanhui Miao, Hangjun Dai, Zhidong Pei, Rong Guo, Qing Zhou, Yanqiu Zhao, Nong Xu, Jianxin Yang, Jingru Wang

Publikováno v: Journal of Clinical Oncology. 38:e21687-e21687

e21687 Background: Immuno-oncology (IO) monotherapy or combination with platinum-based chemo is the current standard of care for pts with PD-L1 expression ≥ 50% and EGFR, ALK, ROS1, BRAF negative advanced NSCLC in China. CS1001-101 phase Ib study i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::899092dc490762e136a54b2f40a80bc1
https://doi.org/10.1200/jco.2020.38.15_suppl.e21687

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání